GETI.B

196.25

-0.1%↓

ATT

103.6

+1.17%↑

AMBEA

132.4

+0.38%↑

ARJOB

26.2

+0.23%↑

MSON.B

11.25

+1.35%↑

GETI.B

196.25

-0.1%↓

ATT

103.6

+1.17%↑

AMBEA

132.4

+0.38%↑

ARJOB

26.2

+0.23%↑

MSON.B

11.25

+1.35%↑

GETI.B

196.25

-0.1%↓

ATT

103.6

+1.17%↑

AMBEA

132.4

+0.38%↑

ARJOB

26.2

+0.23%↑

MSON.B

11.25

+1.35%↑

GETI.B

196.25

-0.1%↓

ATT

103.6

+1.17%↑

AMBEA

132.4

+0.38%↑

ARJOB

26.2

+0.23%↑

MSON.B

11.25

+1.35%↑

GETI.B

196.25

-0.1%↓

ATT

103.6

+1.17%↑

AMBEA

132.4

+0.38%↑

ARJOB

26.2

+0.23%↑

MSON.B

11.25

+1.35%↑

Home・Akciju saraksts・Vivesto AB

Vivesto AB

Slēgts

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

Max

Galvenie mērījumi
By Trading Economics
Ienākumi	-1.9M -9.1M
EPS	-0.013
Darbinieki	4
EBITDA	-1.8M -8.9M

Dividendes
By Dow Jones
Nākamie ieņēmumi	2026. g. 7. maijs

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-124K 51M
Iepriekšējā atvēršanas cena	0
Iepriekšējā slēgšanas cena	0

Vivesto AB Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 6. marts 19:32 UTC

Iegādes, apvienošanās, pārņemšana

Diana Shipping Increases Offer to Acquire Genco -- Update

2026. g. 6. marts 17:44 UTC

Iegādes, apvienošanās, pārņemšana

Lonza to Offload Majority Stake in Capsule Business to Lone Star in $2.2 Billion Deal

2026. g. 6. marts 22:26 UTC

Galvenie ziņu notikumi

Why $100 Oil Is Now in Sight. Who Wins, Who Loses. -- Barrons.com

2026. g. 6. marts 22:07 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

Boeing Says Spirit Acquisition Will Help Improve Safety -- Market Talk

2026. g. 6. marts 22:03 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2026. g. 6. marts 22:03 UTC

Tirgus saruna

Boeing CEO's Pay Nears $24 Million During Recovery Phase -- Market Talk

2026. g. 6. marts 21:50 UTC

Tirgus saruna

Galvenie ziņu notikumi

Financial Services Roundup: Market Talk

2026. g. 6. marts 21:37 UTC

Peļņas

Salesforce Stock Might Not Be an AI Loser After All -- Barrons.com

2026. g. 6. marts 21:25 UTC

Galvenie ziņu notikumi

How The Iran War Impacts Ukraine. -- Barrons.com

2026. g. 6. marts 21:17 UTC

Peļņas

Burlington Stores' Strong Year Should Lift the Stock. What Comes Next. -- Barrons.com

2026. g. 6. marts 20:50 UTC

Peļņas

Marvell Stock Pops 20%. Semiconductor Earnings Show AI Demand Is Strong. -- Barrons.com

2026. g. 6. marts 20:46 UTC

Peļņas

Nike Reports $300 Million Pretax Charge Related to Job Cuts -- Barrons.com

2026. g. 6. marts 20:31 UTC

Galvenie ziņu notikumi

Oil Prices Soar Past $90. Trump Demands 'Unconditional Surrender' From Iran -- and Kuwait Cut Production. -- Barrons.com

2026. g. 6. marts 20:18 UTC

Tirgus saruna

Oil Makes Record Weekly Gains As Strait of Hormuz Stays Shut -- Market Talk

2026. g. 6. marts 20:12 UTC

Tirgus saruna

Galvenie ziņu notikumi

U.S. Natural Gas Futures Gain on Global Energy Turmoil -- Market Talk

2026. g. 6. marts 19:10 UTC

Tirgus saruna

Galvenie ziņu notikumi

$150 Oil Seen As Realistic If Hormuz Closure Lasts -- Market Talk

2026. g. 6. marts 18:54 UTC

Tirgus saruna

Fed's Hammack: Dollar Hasn't Lost Prime Status -- Market Talk

2026. g. 6. marts 18:44 UTC

Tirgus saruna

Galvenie ziņu notikumi

U.S. Oil Rig Count Increases By 4 to 411 -- Market Talk

2026. g. 6. marts 18:08 UTC

Peļņas

Samsara Stock Jumps 16% After Earnings. Why the CEO Isn't Worried About AI. -- Barrons.com

2026. g. 6. marts 18:04 UTC

Peļņas

Marvell Stock Surges on Earnings. It's Not Just a Custom AI Chip Story. -- Barrons.com

2026. g. 6. marts 18:04 UTC

Peļņas

Samsara Stock Jumps 16% After Earnings. Why the CEO Isn't Worried About AI. -- Barrons.com

2026. g. 6. marts 17:49 UTC

Tirgus saruna

AI-Driven Picks-And-Shovels Bet Comes With Risks -- Market Talk

2026. g. 6. marts 17:46 UTC

Galvenie ziņu notikumi

Kuwait Cuts Oil Production as Fallout From Iran Conflict Intensifies -- Update

2026. g. 6. marts 17:40 UTC

Tirgus saruna

Peļņas

Marvell's Long-Term Outlook Well-Received By Investors -- Market Talk

2026. g. 6. marts 17:40 UTC

Peļņas

Marvell Stock Surges on Earnings. It's Not Just a Custom AI Chip Story. -- Barrons.com

2026. g. 6. marts 17:32 UTC

Tirgus saruna

Galvenie ziņu notikumi

No Quick Solution for Hormuz Shipping as U.S. Oil Tops $90 -- Market Talk

2026. g. 6. marts 17:28 UTC

Tirgus saruna

Galvenie ziņu notikumi

Aluminum Rising as Strait of Hormuz Stays Locked -- Market Talk

2026. g. 6. marts 17:20 UTC

Tirgus saruna

Peļņas

Auto & Transport Roundup: Market Talk

2026. g. 6. marts 17:20 UTC

Tirgus saruna

Galvenie ziņu notikumi

Basic Materials Roundup: Market Talk

2026. g. 6. marts 17:20 UTC

Iegādes, apvienošanās, pārņemšana

BlackRock Sticks to Redemption Minimum on Credit Fund, Sends Shares Lower -- WSJ

Salīdzinājums

Cenas izmaiņa

Vivesto AB Prognoze

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Vivesto AB

Vivesto AB develops, produces, markets, and sells drugs in the field of human and veterinary oncology in Sweden. Its lead product is Apealea (paclitaxel micellar) for the treatment of ovarian cancer. The company's products portfolio includes Docetaxel micellar, a patented formulation that combines cytotoxin docetaxel with XR-17, which is in Phase 1b clinical trial for the treatment of prostate cancer; and Cantrixil to treat ovarian cancer. its animal health product portfolio includes Paccal Vet, a formulation of paclitaxel with its XR-17 encapsulation technology for the treatment of canine mastocytoma; and Doxophos Vet, a patented formulation of doxorubicin to treat lymphoma. The company was formerly known as Oasmia Pharmaceutical AB (publ) and changed its name to Vivesto AB in March 2022. Vivesto AB was incorporated in 1988 and is headquartered in Solna, Sweden.